SEC Form SC 13D filed by Captivision Inc.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. )*

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 13d-7(b) for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

(1) The aggregate amount of Ordinary Shares beneficially owned by Mr. Garrabrant is comprised of 715,545 Ordinary Shares and 2,459,083 Ordinary Shares underlying warrants held by Mr. Garrabrant (collectively, the “Securities”).

(2) Percent of class calculated based on an aggregate of 29,030,998 Ordinary Shares issued and outstanding as of June 18, 2024, plus 2,459,083 Ordinary underlying the warrants held by Mr. Garrabrant.

ITEM 1. Security and Issuer.

The securities to which this Schedule 13D relates are the ordinary shares, $0.0001 par value per share (“Ordinary Shares”), of Captivision Inc., a Cayman Islands exempted company limited by shares (the “Issuer”). The principal executive offices of the Issuer are located at 298‑42 Chung‑buk Chungang‑ro Chung‑buk, Pyeong‑taek, Gyounggi, Republic of Korea 17800.

ITEM 2. Identity and Background.

This Schedule 13D is being filed by Gary R. Garrabrant.

The business address of Mr. Garrabrant is 601 Brickell Key Drive, Suite 700, Miami, Florida 33131.

Mr. Garrabrant is the Chairman and Chief Executive Officer of the Issuer, whose principal address is 298‑42 Chung‑buk Chungang‑ro Chung‑buk, Pyeong‑taek, Gyounggi, Republic of Korea 17800. The Issuer’s principal business is digital media technology.

During the last five years, the Mr. Garrabrant has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and, as a result of such proceeding, was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. During the last five years, Mr. Garrabrant has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

Mr. Garrabrant is a citizen of the United States of America.

ITEM 3. Source and Amount of Funds or Other Consideration.

On May 29, 2024, Jaguar Global Growth Partners I, LLC transferred 7,466,667 Ordinary Shares and 11,950,000 Ordinary Shares issuable upon the exercise of 11,950,000 private warrants of the Company, each exercisable for one Ordinary Share (“Private Warrants”) to certain individuals and entities (the “Distribution”).

In connection with the Distribution, Mr. Garrabrant was issued 715,545 Ordinary Shares and 2,459,083 Private Warrants.

ITEM 4. Purpose of Transaction.

The information set forth in or incorporated by reference in Item 3 and Item 6 of this Schedule 13D is hereby incorporated by reference in its entirety into this Item 4.

Mr. Garrabrant is the Chairman and Chief Executive Officer of the Company. Accordingly, Mr. Garrabrant may have influence over the corporate activities of the Issuer, including activities that may relate to items described in clauses (a) through (j) of Item 4 of Schedule 13D. Mr. Garrabrant acquired the securities set forth in Item 5 for investment purposes. Mr. Garrabrant may, from time to time, purchase or sell securities of the Issuer depending upon an ongoing evaluation of the investment in the Ordinary Shares and the warrants, prevailing market conditions, other investment opportunities, other investment considerations and/or other factors.

ITEM 5. Interest in Securities of the Issuer.

The information set forth in or incorporated by reference in Item 2, Item 3 and Item 6 of this Schedule 13D is hereby incorporated by reference in its entirety into this Item 5.

The percentage of the class is calculated based on an aggregate of 29,030,998 Ordinary Shares issued and outstanding as of June 18, 2024, plus 2,459,083 Ordinary Shares underlying the warrants held by the Mr. Garrabrant.

(b) Gary R. Garrabrant:

(1) Sole Voting Power: 3,174,628

(2) Shared Voting Power: 0

(3) Sole Dispositive Power: 3,174,628

(4) Shared Dispositive Power: 0

(c) Except as described in this Schedule 13D, during the past 60 days Mr. Garrabrant has not effected any transactions in the Ordinary Shares.

(d) Not applicable.

(e) Not applicable.

ITEM 6. Contracts, Arrangements, Understandings or Relationship with Respect to the Securities of the Issuer.

The information set forth in or incorporated by reference in Item 3 of this Schedule 13D is hereby incorporated by reference in its entirety into this Item 6.

Sponsor Support Agreement

Mr. Garrabrant is a party to a Sponsor Support Agreement dated as of March 2, 2023, pursuant to which Mr. Garrabrant agreed to subject 62,621 Ordinary Shares received in the Distribution to vesting (or forfeiture if such shares had not vested prior to November 15, 2028 (the “Specified Period”)) upon the later of (A) May 13, 2024 and (B) the date the VWAP for Ordinary Shares is at least $12.50 for 20 trading days within any 30-day consecutive trading day period during the Specified Period.

Registration Rights Agreement

Mr. Garrabrant is a party to the Registration Rights Agreement, dated as of March 2, 2023 (the “Registration Rights Agreement”) with the Issuer and certain other of the Issuer’s shareholders (collectively, the “RRA Parties”). Pursuant to the Registration Rights Agreement, the RRA Parties were granted certain customary registration rights, demand rights and piggyback rights with respect to their respective Ordinary Shares. The Registration Rights Agreement requires the Issuer to file a resale registration statement on behalf of the RRA Parties as soon as practicable but no later than 30 days after consummation of the initial business combination of the Company (the “Business Combination”). The Registration Rights Agreement also provides certain demand rights and piggyback rights to the RRA Parties, in each case subject to certain offering thresholds, applicable lock-up restrictions, issuer suspension periods and certain other conditions. The Registration Rights Agreement includes customary indemnification provisions. The Issuer agreed to pay certain fees and expenses relating to registrations under the Registration Rights Agreement.

The foregoing description does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Sponsor Support Agreement and the Registration Rights Agreement, copies of which are filed with this Schedule 13D as Exhibits 99.1 and 99.2, respectively, and incorporated herein by reference.

Except as described above, no contracts, arrangements, understandings, or relationships (legal or otherwise) exist between Mr. Garrabrant and any person with respect to any securities of the Issuer, including, but not limited to, transfer or voting of any of the securities, finder’s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, divisions of profits or loss, or the giving or withholding of proxies. Except as described above, Mr. Garrabrant is not a party to any arrangement whereby securities of the Issuer are pledged or are otherwise subject

to a contingency the occurrence of which would give another person voting power or investment power over such securities.

ITEM 7. Material to Be Filed as Exhibits.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.